GWAM
ABBV icon

Guardian Wealth Advisors (Minnesota)’s AbbVie ABBV Stock Holding History

Guardian Wealth Advisors (Minnesota)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
4,819
+38
+0.8% +$8.18K 0.61% 16
2026
Q1 		$1.04M Sell
4,781
-349
-7% -$77.4K 0.6% 17
2025
Q4 		$1.17M Sell
5,130
-650
-11% -$148K 0.66% 16
2025
Q3 		$1.34M Sell
5,780
-191
-3% -$38.9K 0.76% 16
2025
Q2 		$1.11M Sell
5,971
-181
-3% -$33.6K 0.66% 19
2025
Q1 		$1.29M Sell
6,152
-366
-6% -$71.2K 0.83% 18
2024
Q4 		$1.16M Sell
6,518
-169
-3% -$31.1K 0.74% 18
2024
Q3 		$1.32M Buy
6,687
+40
+0.6% +$7.46K 0.82% 18
2024
Q2 		$1.14M Sell
6,647
-157
-2% -$26K 0.74% 17
2024
Q1 		$1.24M Sell
6,804
-194
-3% -$33.4K 0.81% 15
2023
Q4 		$1.08M Buy
6,998
+40
+0.6% +$5.83K 0.76% 15
2023
Q3 		$1.04M Buy
6,958
+4
+0.1% +$587 0.79% 16
2023
Q2 		$937K Sell
6,954
-2
-0% -$293 0.69% 18
2023
Q1 		$1.11M Buy
6,956
+347
+5% +$53.1K 0.87% 15
2022
Q4 		$1.07M Sell
6,609
-2
-0% -$307 0.95% 15
2022
Q3 		$887K Buy
6,611
+55
+0.8% +$7.89K 0.86% 18
2022
Q2 		$1M Buy
6,556
+27
+0.4% +$4.13K 0.92% 18
2022
Q1 		$1.06M Sell
6,529
-165
-2% -$24K 0.87% 19
2021
Q4 		$906K Buy
6,694
+148
+2% +$17.5K 0.73% 21
2021
Q3 		$706K Sell
6,546
-618
-9% -$70.6K 0.63% 23
2021
Q2 		$807K Sell
7,164
-117
-2% -$13.2K 0.7% 22
2021
Q1 		$788K Buy
7,281
+24
+0.3% +$2.57K 0.73% 22
2020
Q4 		$778K Buy
+7,257
New +$697K 0.77% 24

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Guardian Wealth Advisors (Minnesota)'s ABBV Position: Q2 2026 in Review

Guardian Wealth Advisors (Minnesota) increased its AbbVie (ABBV) stake by 0.79% in Q2 2026, buying an estimated $8.18K and bringing the position to 4,819 shares worth $1.21M. The position accounts for 0.61% of the portfolio, ranked #16.

Guardian Wealth Advisors (Minnesota) first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.34M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guardian Wealth Advisors (Minnesota) held 4,819 shares of AbbVie worth $1.21M as of Q2 2026.
  • Guardian Wealth Advisors (Minnesota) bought 38 AbbVie shares in Q2 2026, an estimated $8.18K.
  • AbbVie made up 0.61% of Guardian Wealth Advisors (Minnesota)'s portfolio in Q2 2026, its #16 holding.
  • Guardian Wealth Advisors (Minnesota) first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Guardian Wealth Advisors (Minnesota)'s AbbVie position peaked at $1.34M in Q3 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guardian Wealth Advisors (Minnesota)'s 13F filing for Q2 2026, filed 6 Aug 2026.